<DOC>
	<DOCNO>NCT00978315</DOCNO>
	<brief_summary>The study null hypothesis vitamin D supplementation influence time upper respiratory tract infection time severe asthma exacerbation adult adolescent patient asthma .</brief_summary>
	<brief_title>Trial Vitamin D Supplementation Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Principal Medical record diagnosis asthma Age ≥ 16 year ≤ 80 year day first dose IMP If woman childbearing potential , sexually abstinent negative pregnancy test within 7 day recruitment agree use reliable form contraception complete study Able give write informed consent participate study Principal Diagnosis COPD Known sarcoidosis , hyperparathyroidism , nephrolithiasis , active tuberculosis , vitamin D intolerance , liver failure , renal failure , terminal illness , lymphoma malignancy remission ≥ 3 year Any condition , investigator 's judgement , might compromise patient safety compliance , interfere evaluation preclude completion study Taking benzothiadiazine derivative , cardiac glycoside , carbamazepine , phenobarbital , phenytoin primidone Taking dietary supplement contain vitamin D 2 month first dose IMP Treatment investigational medical product device 4 month first dose IMP Breastfeeding , pregnant planning pregnancy Baseline correct serum calcium &gt; 2.65 mmol/L Baseline serum creatinine &gt; 125 micromol/L Smoking history &gt; 15 packyears</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>